CBN has slightly stronger direct evidence for sleep specifically, but the answer depends on why you’re not sleeping well. In the only rigorous clinical trial comparing CBN (with and without CBD) to a placebo, 20 mg of CBN taken nightly reduced the number of times people woke up during the night and improved overall sleep disturbance. CBD, on the other hand, has stronger evidence for reducing anxiety, which makes it more useful when racing thoughts or worry are the reason you can’t sleep.
What the Clinical Evidence Actually Shows
A double-blind, placebo-controlled study of 293 participants tested 20 mg of CBN alone and in combination with various doses of CBD (10, 20, and 100 mg) over seven consecutive nights. The results were mixed but telling. CBN on its own significantly reduced the number of nighttime awakenings and overall sleep disturbance compared to placebo. However, it did not help people fall asleep faster, and it didn’t reduce the total time spent awake in the middle of the night. The improvement in sleep quality trended positive but didn’t reach statistical significance.
The most surprising finding: adding CBD to CBN did not improve outcomes. None of the CBD-plus-CBN groups performed better than CBN alone. This challenges the popular marketing claim that combining the two cannabinoids creates a synergistic “entourage effect” for sleep.
CBD lacks a comparable standalone sleep trial of similar rigor. Most of the evidence for CBD and sleep comes from anxiety studies where sleep improved as a secondary outcome, or from observational reports. That doesn’t mean CBD is useless for sleep. It means its sleep benefits likely come through a different route: calming the nervous system rather than directly promoting sedation.
How Each One Works in the Body
CBD and CBN affect different systems, which explains why they suit different sleep problems.
CBD interacts primarily with serotonin receptors. With repeated use, it increases serotonin activity in the brain by desensitizing the autoreceptors that normally keep serotonin in check. This mechanism closely resembles how traditional anti-anxiety medications work. Reduced serotonin activity is linked to mood and anxiety disorders, so by normalizing that activity, CBD addresses the mental hyperarousal that keeps many people staring at the ceiling.
CBN is a partial activator of the body’s cannabinoid receptors (the same system that THC targets, though CBN is far weaker). It also interacts with pain-sensing channels and receptors involved in inflammation and mood regulation. Its reputation as the “sleepy cannabinoid” originally came from anecdotal reports about aged cannabis, which naturally converts THC to CBN over time. Whether CBN is truly sedating on its own or whether those older observations were confounded by other compounds in aged cannabis remains an open question. The 2024 clinical trial suggests CBN does reduce sleep disruption, but it’s not a knockout sedative.
When CBD Makes More Sense
If your sleep trouble is driven by anxiety, stress, or an overactive mind at bedtime, CBD is the better starting point. Its anti-anxiety effects are well-documented in animal research and supported by a growing number of human studies. By calming the mental noise that prevents sleep onset, CBD targets the root cause rather than trying to override it with sedation. People dealing with chronic pain that disrupts sleep may also benefit from CBD, since it activates pain-modulating channels alongside its serotonin effects.
When CBN Makes More Sense
If you fall asleep fine but wake up multiple times during the night, CBN has more relevant evidence. The clinical trial specifically showed reduced nighttime awakenings, which is a different problem than difficulty falling asleep. CBN also didn’t cause next-day fatigue in the study, which is a common complaint with over-the-counter sleep aids like antihistamines and melatonin at higher doses.
One important caveat: CBN research in humans is still very limited. The 2024 trial is essentially the first rigorous study of CBN alone for sleep. A larger trial (the “CUPID” study) is testing 30 mg and 300 mg doses of CBN in people with diagnosed insomnia disorder, with doses taken two hours before bedtime. Until those results are published, the evidence base for CBN remains thin compared to many other sleep interventions.
Dosage and Timing
In the clinical trial, participants took 20 mg of CBN nightly. This matches the dose range found in most consumer CBN products in the U.S. The upcoming CUPID trial is testing 30 mg and 300 mg to better understand the dose-response relationship. Historical safety studies from the 1970s and 1980s tested oral doses up to 1,200 mg of CBN without major safety concerns, though those studies were small and dated.
For CBD, sleep-related doses in research vary widely, from 25 mg to 300 mg or more, depending on the study and the condition being treated. There is no established standard dose for sleep. Most consumer products designed for sleep contain between 25 and 50 mg of CBD per serving.
Both cannabinoids are taken orally (as oils, capsules, or gummies) and should be taken one to two hours before bed to allow time for absorption. Neither works instantly.
Safety and Drug Interactions
Both CBD and CBN are processed by the same liver enzymes that break down many common medications. A full-spectrum study of 12 cannabinoids found that nearly all of them inhibit one particular enzyme (CYP2C9) at concentrations that could be clinically meaningful. This enzyme is responsible for metabolizing blood thinners like warfarin, certain anti-seizure drugs, and some anti-inflammatory medications. If you take any prescription medication with a narrow margin between a therapeutic and toxic dose, this interaction matters.
CBD also inhibits another liver enzyme (CYP2C19) that processes certain antidepressants and anti-anxiety medications. The irony is that people most likely to try CBD for sleep (those already managing anxiety with medication) are also the most likely to experience an interaction.
Neither CBD nor CBN is FDA-approved as a sleep aid. The only FDA-approved CBD product is a prescription medication for specific seizure disorders. CBD and CBN sleep products sold as supplements exist in a regulatory gray area. They are not tested for purity, potency, or accuracy of labeling before hitting store shelves, and independent testing has repeatedly found that actual cannabinoid content can differ significantly from what’s printed on the label.
The Bottom Line on Choosing
Your choice should match your specific sleep problem. Anxiety keeping you awake points toward CBD. Waking up repeatedly through the night points toward CBN. Neither one will dramatically reduce the time it takes to fall asleep based on current evidence. And despite what many product labels suggest, combining them doesn’t appear to work better than CBN alone for sleep quality. If you’re taking other medications, check for interactions before adding either cannabinoid to your routine.